Is low serum IgM with normal IgG and IgA consistent with selective IgM deficiency?

Low IgM with normal IgG and IgA fits the laboratory phenotype of selective IgM deficiency (sIgMD), but in an 83-year-old man it should be treated as a provisional finding rather than a diagnosis until persistence and secondary causes are addressed.

Diagnostic interpretation

• sIgMD is characterized by repeatedly low or absent IgM—often below 2 standard deviations of age-adjusted norms—with normal IgG and IgA. Thus, preserved class-switched immunoglobulin concentrations are compatible with the condition.
• Confirmation requires at least two low IgM measurements, assessment of IgG subclasses, vaccine-specific antibody responses, and T-cell status/function.
• Secondary explanations must be excluded, particularly medications (including immunosuppressive/B-cell–depleting therapy), hematologic malignancy, protein-losing enteropathy, nephrotic syndrome, thymoma, infection, and other immune disorders. This matters because only 6 of 261 published cases in one review met complete ESID-style criteria.

Mechanistic and clinical implications

• IgM is a potent early effector because antigen-bound pentameric IgM efficiently recruits C1q, initiating classical complement activation through C4 and C3. Low IgM can therefore reduce antigen-specific complement-mediated opsonization and clearance, without implying low complement proteins or abnormal routine complement assays.
• Natural IgM may also aggregate or sterically neutralize pathogens before high-affinity IgG responses develop. In IgM-deficient animal models, deficiency increased bacterial burden, endotoxemia, viral dissemination, and mortality; polyclonal/natural IgM transfer restored or improved protection.
• Human implications are plausible but variable. Recurrent or chronic respiratory infections occurred in 73% of a 62-adult cohort, yet some individuals are asymptomatic and serum IgM concentration does not reliably predict infection burden. IgG may partly compensate for complement activation depending on subclass and immune-complex geometry, but does not necessarily replace IgM’s early multivalent function.

Bottom line

• The claim is broadly well founded: this pattern is consistent with sIgMD and may compromise early neutralization and classical complement activation despite normal IgG/IgA, but diagnosis and functional significance require repeat testing, exclusion of secondary causes, and patient-specific immune/vaccine-response evaluation.